Literature DB >> 12801526

Tumor necrosis factor receptor-associated factor (TRAF) 4 is a new binding partner for the p70S6 serine/threonine kinase.

Diana S Fleckenstein1, Wilhelm G Dirks, Hans G Drexler, Hilmar Quentmeier.   

Abstract

UNLABELLED: p70S6K is an intracellular serine/threonine kinase that mediates cell cycle progression and gene transcription. Immunofluorescent staining shows in factor-dependent hematopoietic M-07e cells that p70S6K is localized both in the cytosol and, after cytokine stimulation, also in the nucleus. We hypothesized that the p70S6K might interact with a transcription factor in the nucleus or with other proteins in the cytosol besides the S6 protein. By screening a yeast two-hybrid HeLa cDNA library with full-length p70S6K cDNA as bait, we identified tumor necrosis factor receptor-associated factor (TRAF) 4 as a new binding partner for this kinase. TRAF4 is a member of the TRAF family of putative signal-transducing proteins. Members of this family are capable of negatively regulating apoptotic pathways by inducing the expression of genes that promote cell survival. Immunoprecipitation experiments showed that stimulation of receptors of the tumor necrosis factor (TNF) family induced the formation of TRAF4/p70S6K complexes. Transfection studies showed that TRAF4 functions in p70S6K activation: TNF induced phosphorylation of S6, the main intracellular substrate of the kinase, in cells stably expressing TRAF4, but not in TRAF4-negative cells. In addition to its role in p70S6K activation, we postulate an anti-apoptotic role for TRAF4, because the agonistic anti-Fas antibody CH-11 induced apoptosis in untransfected HEK-293 cells, but not in TRAF4-expressing HEK-293 cells. IN
CONCLUSION: (i) TNF-receptor activation leads to activation of the p70S6K; (ii) TRAF4 is a mediator in this TNF-induced signaling pathway; and (iii) TRAF4 inhibits Fas-induced apoptosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801526     DOI: 10.1016/s0145-2126(02)00325-9

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  12 in total

1.  miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer.

Authors:  Chao Cai; Qing-Biao Chen; Zhao-Dong Han; Yan-Qiong Zhang; Hui-Chan He; Jia-Hong Chen; Yan-Ru Chen; Sheng-Bang Yang; Yong-Ding Wu; Yan-Ru Zeng; Guo-Qiang Qin; Yu-Xiang Liang; Qi-Shan Dai; Fu-Neng Jiang; Shu-lin Wu; Guo-Hua Zeng; Wei-De Zhong; Chin-Lee Wu
Journal:  Clin Cancer Res       Date:  2015-06-16       Impact factor: 12.531

2.  Acute tumor necrosis factor alpha signaling via NADPH oxidase in microvascular endothelial cells: role of p47phox phosphorylation and binding to TRAF4.

Authors:  Jian-Mei Li; Lampson M Fan; Michael R Christie; Ajay M Shah
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

3.  Phosphorylation of Leukotriene C4 Synthase at Serine 36 Impairs Catalytic Activity.

Authors:  Shabbir Ahmad; A Jimmy Ytterberg; Madhuranayaki Thulasingam; Fredrik Tholander; Tomas Bergman; Roman Zubarev; Anders Wetterholm; Agnes Rinaldo-Matthis; Jesper Z Haeggström
Journal:  J Biol Chem       Date:  2016-06-30       Impact factor: 5.157

4.  Blocking Stemness and Metastatic Properties of Ovarian Cancer Cells by Targeting p70S6K with Dendrimer Nanovector-Based siRNA Delivery.

Authors:  Jing Ma; Shashwati Kala; Susan Yung; Tak Mao Chan; Yu Cao; Yifan Jiang; Xiaoxuan Liu; Suzanne Giorgio; Ling Peng; Alice S T Wong
Journal:  Mol Ther       Date:  2017-11-16       Impact factor: 11.454

5.  Cytoplasmic TRAF4 contributes to the activation of p70s6k signaling pathway in breast cancer.

Authors:  Hua-Yan Ren; Jian Wang; Fan Yang; Xiao-Li Zhang; Ai-Lian Wang; Li-Li Sun; Ke-Xin Diao; En-Hua Wang; Xiao-Yi Mi
Journal:  Oncotarget       Date:  2015-02-28

6.  Bcl-2 knockdown accelerates T cell receptor-triggered activation-induced cell death in jurkat T cells.

Authors:  Yun-Jung Lee; Tae Joon Won; Kyeong Eun Hyung; Mi Ji Lee; Young-Hye Moon; Ik Hee Lee; Byung Sung Go; Kwang Woo Hwang
Journal:  Korean J Physiol Pharmacol       Date:  2014-02-13       Impact factor: 2.016

7.  Expression and anti-apoptotic function of TRAF4 in human breast cancer MCF-7 cells.

Authors:  Xiaoli Zhang; Zhifeng Wen; Xiaoyi Mi
Journal:  Oncol Lett       Date:  2013-11-25       Impact factor: 2.967

8.  Oncogenomics of c-Myc transgenic mice reveal novel regulators of extracellular signaling, angiogenesis and invasion with clinical significance for human lung adenocarcinoma.

Authors:  Yari Ciribilli; Jürgen Borlak
Journal:  Oncotarget       Date:  2017-10-23

9.  Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study.

Authors:  Li Gao; Sheng-Hua Li; Yi-Xin Tian; Qing-Qing Zhu; Gang Chen; Yu-Yan Pang; Xiao-Hua Hu
Journal:  Onco Targets Ther       Date:  2017-07-20       Impact factor: 4.147

10.  TRAF4, at the Crossroad between Morphogenesis and Cancer.

Authors:  Adrien Rousseau; Marie-Christine Rio; Fabien Alpy
Journal:  Cancers (Basel)       Date:  2011-06-21       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.